The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome
| Autor: | Gerrit Veen, Marc A. Brouwer, Freek W.A. Verheugt, Wim R.M. Aengevaeren, Peter C. Kievit |
|---|---|
| Přispěvatelé: | Cardiology, ICaR - Heartfailure and pulmonary arterial hypertension |
| Rok vydání: | 2009 |
| Předmět: |
Male
medicine.medical_specialty Reduced risk medicine.medical_treatment Population Myocardial Infarction Antithrombotic treatment Fibrinolytic Agents Risk Factors Internal medicine Fibrinolysis Secondary Prevention medicine Humans Thrombolytic Therapy Myocardial infarction education Vascular Patency Aged education.field_of_study Hematology medicine.diagnostic_test Cardiovascular diseases [NCEBP 14] business.industry Smoking Middle Aged medicine.disease Treatment Outcome medicine.anatomical_structure Angiography Cardiology Female business Cardiology and Cardiovascular Medicine Follow-Up Studies Artery |
| Zdroj: | Journal of Thrombosis and Thrombolysis, 27(4), 385-393. Springer Netherlands Journal of Thrombosis and Thrombolysis, 27, 385-93 Kievit, P C, Brouwer, M, Veen, G, Aengevaeren, W R M & Verheugt, F W 2009, ' The smoker's paradox after successful fibrinolysis: reduced risk of reocclusion but no improved long-term cardiac outcome ', Journal of Thrombosis and Thrombolysis, vol. 27, no. 4, pp. 385-393 . https://doi.org/10.1007/s11239-008-0238-6 Journal of Thrombosis and Thrombolysis, 27, 4, pp. 385-93 |
| ISSN: | 0929-5305 |
| DOI: | 10.1007/s11239-008-0238-6 |
| Popis: | Contains fulltext : 81178.pdf (Publisher’s version ) (Closed access) BACKGROUND: In smokers treated with fibrinolysis for ST-elevation myocardial infarction (STEMI) a paradoxical beneficial short-term outcome has been reported. This was attributed to favorable clinical and angiographic baseline variables and a better response to fibrinolysis. During follow-up infarct artery reocclusion is an important prognosticator. We studied the effects of smoking on reocclusion and long-term cardiac outcome after successful fibrinolysis. METHODS: In the Antithrombotics in the Prevention of Reocclusion In COronary Thrombolysis trials (APRICOT-1 and -2) 499 STEMI patients with an open infarct artery |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink